Significance of palliative gastrectomy for late-stage gastric cancer patients

Journal of Surgical Oncology

Volumn 106, Issue 7, 2012, Pages 862-871

  Chen, Shi ^a   Li, Yuan Fang ^a   Feng, Xing Yu ^a   Zhou, Zhi Wei ^a   Yuan, Xiu Hong ^a   Chen, Ying Bo ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

combined hepatectomy; late stage gastric cancer; palliative gastrectomy; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PERITONEAL DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STOMACH CANCER; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTRECTOMY; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALLIATIVE CARE; PERITONEUM; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84868342804     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23158     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
2. Crew KD, Neugut AI,: Epidemiology of gastric cancer. World J Gastroenterol 2006; 12: 354-362.
3. Zhan YQ, Li W, Sun XW, et al.: [Long-term results of surgical treatment of stomach cancer: Clinical experience of forty years from Sun Yat-sen University Cancer Center]. Zhonghua Wai Ke Za Zhi 2005; 43: 1109-1113.
4. Broll R, Weschta M, Windhoevel U, et al.: Prognostic significance of free gastrointestinal tumor cells in peritoneal lavage detected by immunocytochemistry and polymerase chain reaction. Langenbecks Arch Surg 2001; 386: 285-292.
5. Nakanishi H, Kodera Y, Yamamura Y, et al.: Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecologic malignancies. Cancer Chemother Pharmacol 1999; 43: S32-S36.
6. Marrelli D, Roviello F, De Stefano A, et al.: Risk factors for liver metastases after curative surgical procedures for gastric cancer: A prospective study of 208 patients treated with surgical resection. J Am Coll Surg 2004; 198: 51-58.
7. Okano K, Maeba T, Ishimura K, et al.: Hepatic resection for metastatic tumors from gastric cancer. Ann Surg 2002; 235: 86-91.
8. Zacherl J, Zacherl M, Scheuba C, et al.: Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma. J Gastrointest Surg 2002; 6: 682-689.
9. Glimelius B, Ekstrom K, Hoffman K, et al.: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 1997; 8: 163-168.
10. Pyrhonen S, Kuitunen T, Nyandoto P, et al.: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 1995; 71: 587-591.
11. Bang YJ, Van Cutsem E, Feyereislova A, et al.: Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomised controlled trial. Lancet 2010; 376: 687-697.
12. Ambiru S, Miyazaki M, Ito H, et al.: Benefits and limits of hepatic resection for gastric metastases. Am J Surg 2001; 181: 279-283.
13. Miyazaki M, Itoh H, Nakagawa K, et al.: Hepatic resection of liver metastases from gastric carcinoma. Am J Gastroenterol 1997; 92: 490-493.
14. Shirabe K, Wakiyama S, Gion T, et al.: Hepatic resection for the treatment of liver metastases in gastric carcinoma: Review of the literature. HPB (Oxford) 2006; 8: 89-92.
15. Sakamoto Y, Ohyama S, Yamamoto J, et al.: Surgical resection of liver metastases of gastric cancer: An analysis of a 17-year experience with 22 patients. Surgery 2003; 133: 507-511.
16. Yasumoto K, Koizumi K, Kawashima A, et al.: Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 2006; 66: 2181-2187.
17. Bando E, Yonemura Y, Takeshita Y, et al.: Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. Am J Surg 1999; 178: 256-262.
18. Verwaal VJ, Long-term results of cytoreduction HIPEC followed by systemic chemotherapy. Cancer J 2009; 15: 212-215.
19. Yang XJ, Li Y, al-shammaa Hassan AH, et al.: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: Results of 21 cases. Ann Surg Oncol 2009; 16: 345-351.
20. van Leeuwen BL, Graf W, Pahlman L, et al.: Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis. Ann Surg Oncol 2008; 15: 745-753.
21. Esquivel J, Technology of hyperthermic intraperitoneal chemotherapy in the United States Europe, China, Japan, and Korea Cancer J 2009; 15: 249-254.
22. Cuschieri A, Weeden S, Fielding J, et al.: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999; 79: 1522-1530.
23. Hartgrink HH, van de Velde CJ, Putter H, et al.: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 2004; 22: 2069-2077.
24. Wu CW, Hsiung CA, Lo SS, et al.: Nodal dissection for patients with gastric cancer: A randomised controlled trial. Lancet Oncol 2006; 7: 309-315.
25. Aloia TA, Vauthey JN, Loyer EM, et al.: Solitary colorectal liver metastasis: Resection determines outcome. Arch Surg 2006; 141: 460-466; discussion 6-7.
26. Kokudo N, Tada K, Seki M, et al.: Anatomical major resection versus nonanatomical limited resection for liver metastases from colorectal carcinoma. Am J Surg 2001; 181: 153-159.
27. Hirai I, Kimura W, Fuse A, et al.: Surgical management for metastatic liver tumors. Hepatogastroenterology 2006; 53: 757-763.
28. Zibari GB, Riche A, Zizzi HC, et al.: Surgical and nonsurgical management of primary and metastatic liver tumors. Am Surg 1998; 64: 211-220; discussion 20-21.
29. Ochiai T, Sasako M, Mizuno S, et al.: Hepatic resection for metastatic tumours from gastric cancer: Analysis of prognostic factors. Br J Surg 1994; 81: 1175-1178.
30. Sakamoto Y, Sano T, Shimada K, et al.: Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer. J Surg Oncol 2007; 95: 534-539.
31. Imamura H, Matsuyama Y, Shimada R, et al.: A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol 2001; 96: 3178-3184.
32. Elias D, Cavalcanti deAlbuquerque A, Eggenspieler P, et al.: Resection of liver metastases from a noncolorectal primary: Indications and results based on 147 monocentric patients. J Am Coll Surg 1998; 187: 487-493.
33. Shirabe K, Shimada M, Matsumata T, et al.: Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: A multi-institutional study of the indications for resection. Hepatogastroenterology 2003; 50: 1560-1563.
34. Shchepotin IB, Chorny VA, Nauta RJ, et al.: Extended surgical resection in T4 gastric cancer. Am J Surg 1998; 175: 123-126.
35. Maehara Y, Oiwa H, Tomisaki S, et al.: Prognosis and surgical treatment of gastric cancer invading the pancreas. Oncology 2000; 59: 1-6.
36. Sano T,: Adjuvant and neoadjuvant therapy of gastric cancer: A comparison of three pivotal studies. Curr Oncol Rep 2008; 10: 191-198.
37. Ajani JA, Mansfield PF, Janjan N, et al.: Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol 2004; 22: 2774-2780.
38. Macdonald JS, Smalley SR, Benedetti J, et al.: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-730.
39. Yasuda K, Shiraishi N, Adachi Y, et al.: Risk factors for complications following resection of large gastric cancer. Br J Surg 2001; 88: 873-877.
40. Martin RC II, Jaques DP, Brennan MF, et al.: Achieving RO resection for locally advanced gastric cancer: Is it worth the risk of multiorgan resection? J Am Coll Surg 2002; 194: 568-577.
41. Kodama I, Takamiya H, Mizutani K, et al.: Gastrectomy with combined resection of other organs for carcinoma of the stomach with invasion to adjacent organs: Clinical efficacy in a retrospective study. J Am Coll Surg 1997; 184: 16-22.